Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis ,
, Ann N Y Acad Sci, vol.465, pp.643-656, 1986.
Clinico-epidemiological features of pulmonary histiocytosis X, Intern Med, vol.40, pp.998-1003, 2001. ,
, Recurrent BRAF mutations in Langerhans cell histiocytosis, vol.116, pp.1919-1923, 2010.
High prevalence of somatic MAP2K1 mutations in BRAF V600E negative Langerhans cell histiocytosis, Blood, vol.124, issue.10, pp.1655-1658, 2014. ,
Somatic activating ARAF mutations in Langerhans cell histiocytosis, Blood, vol.123, pp.3152-3155, 2014. ,
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups, J Exp Med, vol.211, pp.669-683, 2014. ,
Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X, Chest, vol.98, pp.765-767, 1990. ,
Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation, Chest, vol.115, pp.1452-1455, 1999. ,
Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis, Am J Respir Crit Care Med, vol.157, pp.2007-2010, 1998. ,
Pulmonary langerhans cell histiocytosis, Orphanet J Rare Dis, vol.7, p.16, 2012. ,
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy, J Clin Invest, vol.86, pp.1480-1488, 1990. ,
Rosenblatt JD: 2-Chlorodeoxyadenosine to treat refractory histiocytosis X, N Engl J Med, vol.329, pp.734-735, 1993. ,
DL: 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients, Med Pediatr Oncol, vol.29, pp.288-292, 1997. ,
Cladribine activity in adult langerhans-cell histiocytosis, Blood, vol.93, pp.4125-4130, 1999. ,
Tefferi A: 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis, Mayo Clin Proc, vol.78, pp.301-306, 2003. ,
Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy, Thorax, vol.64, pp.274-275, 2009. ,
Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker, Respir Med, vol.102, pp.316-319, 2008. ,
Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine, Respirology, vol.8, pp.91-94, 2003. ,
Cladribine is effective against cystic pulmonary Langerhans cell histiocytosis, Am J Respir Crit Care Med, vol.186, pp.930-932, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00873182
Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis?, Am J Respir Crit Care Med, vol.162, pp.264-270, 2000. ,
Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis, Chest, vol.135, pp.1542-1549, 2009. ,
Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension, vol.112, pp.1142-1144, 1997. ,
Severe pulmonary hypertension in histiocytosis X, Am J Respir Crit Care Med, vol.161, pp.216-223, 2000. ,
Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis, Orphanet Journal of Rare Diseases, vol.9, p.191, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02192909